In Illinois, researchers discovered how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma, develops and found a compound that can flip the switch on cancer-promoting genes turning them off so the tumor shrinks. Researchers used biopsied tumor samples from patients to create the lab models and it took less than two years for them to make the discovery. Considering only 5 percent of children with this brain tumor survive, being able to shrink tumors and increase survival rates in animal models is giving major hope for children and their parents. Clinical trials will begin at the Ann & Robert H. Lurie Children’s Hospital of Chicago by the end of the year.
Latest article
Biobased sunglasses assist British special forces team with record-breaking Everest trek
In Nepal, four former British special forces soldiers were outfitted with bioplastic sunglasses from Teysha Technologies as they set a mountaineering record for traveling...
Diaper duty development: Hiro unveils nappy-eating fungi
In Texas, a startup has introduced a new diaper concept that aims to address one of the biggest challenges parents face: balancing sustainability with...
von Holzhausen creates “Ripple shoe” from proprietary renewable material
In California, sustainable material firm von Holzhausen has made a 100% biodegradable and plastic-free shoe from Liquidplant™, a polyurethane-like material developed in house out...